Andrew Klein

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Early use of ACE inhibitors in the treatment of acute myocardial infarction in the United States: experience from the National Registry of Myocardial Infarction 2. National Registry of Myocardial Infarction 2 participants
    A D Michaels
    University of California at San Francisco 94143 0124, USA
    Am J Cardiol 84:1176-81. 1999
  2. ncbi The effects of enhanced external counterpulsation on myocardial perfusion in patients with stable angina: a multicenter radionuclide study
    Andrew D Michaels
    Division of Cardiology, University of California, San Francisco Medical Center, San Francisco, California 94143 0124, USA
    Am Heart J 150:1066-73. 2005
  3. ncbi Two-year outcomes after enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry [IEPR])
    Andrew D Michaels
    Division of Cardiology, Department of Medicine, University of California at San Francisco Medical Center, San Francisco, California 94143 0124, USA
    Am J Cardiol 93:461-4. 2004
  4. ncbi Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake
    Andrew D Michaels
    Division of Cardiology, Department of Medicine, University of California at San Francisco Medical Center, 505 Parnassus Ave, Box 0124, San Francisco, Calif 94143 0124, USA
    Circulation 107:2697-701. 2003
  5. ncbi Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation
    Andrew D Michaels
    Division of Cardiology, Department of Medicine, University of California at San Francisco Medical Center, San Francisco, Calif 94143 0124, USA
    Circulation 106:1237-42. 2002
  6. ncbi Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial
    Andrew D Michaels
    University of California at San Francisco Medical Center, Division of Cardiology, 505 Parnassus Avenue, Box 0124, San Francisco, CA 94143 0124, USA
    J Invasive Cardiol 14:299-302. 2002
  7. ncbi Use of a percutaneous arterial suture device (Perclose) in patients undergoing percutaneous balloon aortic valvuloplasty
    A D Michaels
    Department of Medicine, Division of Cardiology, Cardiovascular Research Institute, University of California, San Francisco Medical Center, San Francisco, California 94143 0124, USA
    Catheter Cardiovasc Interv 53:445-7. 2001
  8. ncbi Intracoronary measurement of pulsus alternans
    A D Michaels
    Department of Medicine, Division of Cardiology, University of California San Francisco Medical Center, San Francisco, California 94143, USA
    Catheter Cardiovasc Interv 51:335-8. 2000
  9. ncbi Risk stratification after acute myocardial infarction in the reperfusion era
    A D Michaels
    Department of Medicine, University of California at San Francisco Medical Center, 94143 0124, USA
    Prog Cardiovasc Dis 42:273-309. 2000
  10. ncbi Long-term mortality, cause of death, and temporal trends in complications after percutaneous aortic balloon valvuloplasty for calcific aortic stenosis
    Andrew Klein
    Division of Cardiology, Department of Medicine, University of California at San Francisco Medical Center, San Francisco, California, USA
    J Interv Cardiol 19:269-75. 2006

Detail Information

Publications11

  1. ncbi Early use of ACE inhibitors in the treatment of acute myocardial infarction in the United States: experience from the National Registry of Myocardial Infarction 2. National Registry of Myocardial Infarction 2 participants
    A D Michaels
    University of California at San Francisco 94143 0124, USA
    Am J Cardiol 84:1176-81. 1999
    ..However, most patients hospitalized with AMI do not receive this potentially life-saving therapy...
  2. ncbi The effects of enhanced external counterpulsation on myocardial perfusion in patients with stable angina: a multicenter radionuclide study
    Andrew D Michaels
    Division of Cardiology, University of California, San Francisco Medical Center, San Francisco, California 94143 0124, USA
    Am Heart J 150:1066-73. 2005
    ..One- and two-center studies and a retrospective case series reported that EECP improves myocardial perfusion in stable angina pectoris. We sought to critically evaluate and quantify the effect of EECP on myocardial perfusion...
  3. ncbi Two-year outcomes after enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry [IEPR])
    Andrew D Michaels
    Division of Cardiology, Department of Medicine, University of California at San Francisco Medical Center, San Francisco, California 94143 0124, USA
    Am J Cardiol 93:461-4. 2004
    ....
  4. ncbi Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake
    Andrew D Michaels
    Division of Cardiology, Department of Medicine, University of California at San Francisco Medical Center, 505 Parnassus Ave, Box 0124, San Francisco, Calif 94143 0124, USA
    Circulation 107:2697-701. 2003
    ..Nesiritide, recombinant human B-type natriuretic peptide, has been shown to be efficacious in the treatment of decompensated heart failure. The effects of intravenous nesiritide on the human coronary vasculature have not been studied...
  5. ncbi Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation
    Andrew D Michaels
    Division of Cardiology, Department of Medicine, University of California at San Francisco Medical Center, San Francisco, Calif 94143 0124, USA
    Circulation 106:1237-42. 2002
    ..However, the physiological effects of EECP have not been studied directly. We examined intracoronary and left ventricular hemodynamics in the cardiac catheterization laboratory during EECP...
  6. ncbi Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial
    Andrew D Michaels
    University of California at San Francisco Medical Center, Division of Cardiology, 505 Parnassus Avenue, Box 0124, San Francisco, CA 94143 0124, USA
    J Invasive Cardiol 14:299-302. 2002
    ..Intragraft verapamil is effective in treating no-reflow during saphenous vein graft (SVG) percutaneous coronary intervention (PCI). In this study, we assessed the use of intragraft verapamil given pre-PCI to prevent no-reflow...
  7. ncbi Use of a percutaneous arterial suture device (Perclose) in patients undergoing percutaneous balloon aortic valvuloplasty
    A D Michaels
    Department of Medicine, Division of Cardiology, Cardiovascular Research Institute, University of California, San Francisco Medical Center, San Francisco, California 94143 0124, USA
    Catheter Cardiovasc Interv 53:445-7. 2001
    ..The use of the "Preclose" technique for closure of femoral arteriotomies after balloon aortic valvuloplasty is feasible and associated with a low rate of periprocedural and short-term vascular complications...
  8. ncbi Intracoronary measurement of pulsus alternans
    A D Michaels
    Department of Medicine, Division of Cardiology, University of California San Francisco Medical Center, San Francisco, California 94143, USA
    Catheter Cardiovasc Interv 51:335-8. 2000
    ..Pulsus alternans was demonstrated in the mid LAD using a 0.014" guidewire-mounted pressure sensor. An abnormal fractional flow reserve was measured in the LAD. Cathet. Cardiovasc. Intervent. 51:335-338, 2000...
  9. ncbi Risk stratification after acute myocardial infarction in the reperfusion era
    A D Michaels
    Department of Medicine, University of California at San Francisco Medical Center, 94143 0124, USA
    Prog Cardiovasc Dis 42:273-309. 2000
    ..The current understanding of the clinically important predictors of clinical outcomes in survivors of AMI is reviewed in this article...
  10. ncbi Long-term mortality, cause of death, and temporal trends in complications after percutaneous aortic balloon valvuloplasty for calcific aortic stenosis
    Andrew Klein
    Division of Cardiology, Department of Medicine, University of California at San Francisco Medical Center, San Francisco, California, USA
    J Interv Cardiol 19:269-75. 2006
    ..The decrease in the complication rate over the past 15 years has important implications regarding the morbidity associated with percutaneous aortic valve replacement techniques...
  11. ncbi Pulmonary endarterectomy
    Andrew Roscoe
    Department of Anaesthesia, Wythenshawe Hospital, Manchester, UK
    Curr Opin Anaesthesiol 21:16-20. 2008
    ..This review will look at the new research in the pathophysiology of the disease and developments in perioperative care, which may help to understand the difference in outcomes...